Purpose: To determine the influence of comorbidities on the LOS of COVID-19 patients in KNH-IDU between 1st June 2020 and 30th November 2020 Materials and Methods: This retrospective cohort study comprised of 558 COVID-19 patients of which 69% survived and 31% died. The overall median LOS was 7.5 days (IQR: 0-183) – 8 days (IQR: 1-171) for the survivors, and 6 days (IQR: 0-183) for the non survivors. Data was extracted from hospital records using a questionnaire and analyzed with STATA version 15. Chi-square tests determined associations, while regression analysis examined LOS determinants based on model coefficients and significance. Findings: Significant differences were seen in age (p<0.01), with more survivors aged 20-40 years and non-survivors aged over 40 years. Non-survivors had higher referral rates (p<.001), ICU admissions (p<.001), and intubation needs (p<.001). Diabetes and hypertension were more common in non-survivors (p<.001). Non-survivors also had higher WBC counts (p<.001), higher neutrophil counts (p<.01), lower lymphocyte counts (p<.001), and lower platelet counts (p<.001). Implications to Theory, Practices and Policy: Practically, the findings underscore the need for targeted clinical management strategies, particularly for younger patients and those with severe disease, to optimize LOS and improve survival rates.
No takes yet. Share an insight, caveat, or question.
Manyeki et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: